Product Description: Efdamrofusp alfa is a bispecific fusion protein. Efdamrofusp alfa is capable of neutralizing both VEGF isoforms and C3b/C4b. Efdamrofusp alfa can be used for the research of neovascular age-related macular degeneration (nAMD) and other complement-related ocular conditions[1].
Applications: Neuroscience-Neuromodulation
Formula: N/A
References: [1]Shiqi Yang, et al. Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy. Sci Transl Med. 2022 Jun;14(647):eabj2177.
CAS Number: 2375661-82-6
Molecular Weight: N/A
Research Area: Neurological Disease; Cardiovascular Disease